Extracellular Hb enhances cardiac toxicity in endotoxemicguinea Pigs: Protective role of haptoglobin

Toxins

Volumn 6, Issue 4, 2014, Pages 1244-1259

  Baek, Jin Hyen ^a   Zhang, Xiaoyuan ^a   Williams, Matthew C ^a   Schaer, Dominik J ^b   Buehler, Paul W ^a   D'Agnillo, Felice ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Endothelium; Endotoxin; Haptoglobin; Hemoglobin; Myocardial injury

Indexed keywords

CD163 ANTIGEN; DIAMINOBENZIDINE; EXTRACELLULAR HEMOGLOBIN; HAPTOGLOBIN; HEME OXYGENASE 1; HEMOGLOBIN; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; UNCLASSIFIED DRUG; HP PROTEIN, HUMAN; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DNA DAMAGE; ENDOTOXEMIA; GLOMERULUS FILTRATION; GUINEA PIG; HEART MUSCLE INJURY; HEART PROTECTION; IMMUNOFLUORESCENCE; MALE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED; COMPLICATION; DISEASE MODEL; HEART DISEASES; HEART MUSCLE; METABOLISM; PATHOLOGY; PHAGOCYTOSIS; SEPSIS; TOXICITY;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; DNA DAMAGE; ENDOTOXEMIA; GUINEA PIGS; HAPTOGLOBINS; HEART DISEASES; HEME OXYGENASE-1; HEMOGLOBINS; IRON; LIPOPOLYSACCHARIDES; MALE; MYOCARDIUM; PHAGOCYTOSIS; SEPSIS;

EID: 84897513452     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins6041244     Document Type: Article

References (37)

1. Zanotti-Cavazzoni, S.L.; Hollenberg, S.M. Cardiac dysfunction in severe sepsis and septic shock. Curr. Opin. Crit Care 2009, 15, 392-397.
2. Flynn, A.; Chokkalingam Mani, B.; Mather, P.J. Sepsis-induced cardiomyopathy: A review of pathophysiologic mechanisms. Heart Fail Rev. 2010, 15, 605-611.
3. Balija, T.M.; Lowry, S.F. Lipopolysaccharide and sepsis-associated myocardial dysfunction. Curr. Opin. Infect. Dis. 2011, 24, 248-253.
4. Suliman, H.B.; Welty-Wolf, K.E.; Carraway, M.; Tatro, L.; Piantadosi, C.A. Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc. Res. 2004, 64, 279-288.
5. Su, D.; Roth, R.I.; Yoshida, M.; Levin, J. Hemoglobin increases mortality from bacterial endotoxin. Infect. Immun. 1997, 65, 1258-1266.
6. Krishnamurti, C.; Carter, A.J.; Maglasang, P.; Hess, J.R.; Cutting, M.A.; Alving, B.M. Cardiovascular toxicity of human cross-linked hemoglobin in a rabbit endotoxemia model. Crit. Care Med. 1997, 25, 1874-1880.
7. McGahan, M.C.; Grimes, A.M.; Fleisher, L.N. Hemoglobin exacerbates the ocular inflammatory response to endotoxin. Graefes Arch. Clin. Exp. Ophthalmol. 1996, 234, 643-647.
8. Larsen, R.; Gozzelino, R.; Jeney, V.; Tokaji, L.; Bozza, F.A.; Japiassu, A.M.; Bonaparte, D.; Cavalcante, M.M.; Chora, A.; Ferreira, A.; et al. A central role for free heme in the pathogenesis of severe sepsis. Sci. Transl. Med. 2010, 2, doi:10.1126/scitranslmed.3001118.
9. Adamzik, M.; Hamburger, T.; Petrat, F.; Peters, J.; de Groot, H.; Hartmann, M. Free hemoglobin concentration in severe sepsis: Methods of measurement and prediction of outcome. Crit. Care 2012, 16, R125.
10. Janz, D.R.; Bastarache, J.A.; Peterson, J.F.; Sills, G.; Wickersham, N.; May, A.K.; Roberts, L.J., 2nd; Ware, L.B. Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: An observational study. Crit. Care Med. 2013, 41, 784-790.
11. Janz, D.R.; Bastarache, J.A.; Sills, G.; Wickersham, N.; May, A.K.; Bernard, G.R.; Ware, L.B. Association between haptoglobin, hemopexin and mortality in adults with sepsis. Crit. Care 2013, 17, R272.
12. Smithies, O.; Connell, G.E.; Dixon, G.H. Inheritance of haptoglobin subtypes. Am. J. Hum. Genet. 1962, 14, 14-21.
13. Nosslin, B.F.; Nyman, M. Haptoglobin determination in diagnosis of haemolytic diseases. Lancet 1958, 1, 1000-1001.
14. Andersen, C.B.; Torvund-Jensen, M.; Nielsen, M.J.; de Oliveira, C.L.; Hersleth, H.P.; Andersen, N.H.; Pedersen, J.S.; Andersen, G.R.; Moestrup, S.K. Structure of the haptoglobin-haemoglobin complex. Nature 2012, 489, 456-459.
15. Connell, G.E.; Dixon, G.H.; Smithies, O. Subdivision of the three common haptoglobin types based on "hidden" differences. Nature 1962, 193, 505-506.
16. Boretti, F.S.; Buehler, P.W.; D'Agnillo, F.; Kluge, K.; Glaus, T.; Butt, O.I.; Jia, Y.; Goede, J.; Pereira, C.P.; Maggiorini, M.; et al. Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs. J. Clin. Invest 2009, 119, 2271-2280.
17. Lim, S.K.; Kim, H.; Lim, S.K.; bin Ali, A.; Lim, Y.K.; Wang, Y.; Chong, S.M.; Costantini, F.; Baumman, H. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 1998, 92, 1870-1877.
18. Hashimoto, K.; Nomura, K.; Nakano, M.; Sasaki, T.; Kurosawa, H. Pharmacological intervention for renal protection during cardiopulmonary bypass. Heart Vessel. 1993, 8, 203-210.
19. Bunn, H.F.; Jandl, J.H. The renal handling of hemoglobin. II. Catabolism. J. Exp. Med. 1969, 129, 925-934.
20. Schindhelm, R.K.; van der Zwan, L.P.; Teerlink, T.; Scheffer, P.G. Myeloperoxidase: A useful biomarker for cardiovascular disease risk stratification? Clin. Chem. 2009, 55, 1462-1470.
21. Kaca, W.; Roth, R.I.; Levin, J. Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J. Biol. Chem. 1994, 269, 25078-25084.
22. Bahl, N.; Du, R.; Winarsih, I.; Ho, B.; Tucker-Kellogg, L.; Tidor, B.; Ding, D.L. Delineation of lipopolysaccharide (LPS)-binding sites on hemoglobin: From in silico predictions to biophysical characterization. J. Biol. Chem. 2011, 286, 37793-37803.
23. Bodet, C.; Chandad, F.; Grenier, D. Hemoglobin and LPS act in synergy to amplify the inflammatory response. J. Dent. Res. 2007, 86, 878-882.
24. Gorczynski, R.M.; Alexander, C.; Bessler, W.; Fournier, K.; Hoffmann, P.; Mach, J.P.; Manuel, J.; Ramakrishna, V.; Rietschel, E.T.; Song, L.; et al. Characterization of an interaction between fetal hemoglobin and lipid A of LPS resulting in augmented induction of cytokine production in vivo and in vitro. Int. Immunopharmacol. 2004, 4, 1859-1872.
25. Luchtemberg, M.N.; Petronilho, F.; Constantino, L.; Gelain, D.P.; Andrades, M.; Ritter, C.; Moreira, J.C.; Streck, E.L.; Dal-Pizzol, F. Xanthine oxidase activity in patients with sepsis. Clin. Biochem. 2008, 41, 1186-1190.
26. Wu, J.; Xu, H.; Yang, M.; Martin, C.M.; Kvietys, P.R.; Rui, T. NADPH oxidase contributes to conversion of cardiac myocytes to a proinflammatory phenotype in sepsis. Free Radic. Biol. Med. 2009, 46, 1338-1345.
27. Kothari, N.; Keshari, R.S.; Bogra, J.; Kohli, M.; Abbas, H.; Malik, A.; Dikshit, M.; Barthwal, M.K. Increased myeloperoxidase enzyme activity in plasma is an indicator of inflammation and onset of sepsis. J. Crit. Care 2011, 26, 435. e1-435. e7.
28. Gao, M.; Ha, T.; Zhang, X.; Liu, L.; Wang, X.; Kelley, J.; Singh, K.; Kao, R.; Gao, X.; Williams, D.; et al. Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis. Crit. Care Med. 2012, 40, 2390-2399.
29. Huet, O.; Dupic, L.; Harrois, A.; Duranteau, J. Oxidative stress and endothelial dysfunction during sepsis. Front. Biosci. 2011, 16, 1986-1995.
30. Cheng, W.E.; Shih, C.M.; Hang, L.W.; Wu, K.Y.; Yang, H.L.; Hsu, W.H.; Hsia, T.C. Urinary biomarker of oxidative stress correlating with outcome in critically septic patients. Intensive Care Med. 2007, 33, 1187-1190.
31. Buehler, P.W.; D'Agnillo, F. Toxicological consequences of extracellular hemoglobin: biochemical and physiological perspectives. Antioxid. Redox. Signal. 2010, 12, 275-291.
32. D'Agnillo, F. Redox active hemoglobin enhances lipopolysaccharide-induced injury to cultured bovine endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2004, 287, H1875-H1882.
33. Langheinrich, A.C.; Ritman, E.L. Quantitative imaging of microvascular permeability in a rat model of lipopolysaccharide-induced sepsis: Evaluation using cryostatic micro-computed tomography. Invest Radiol. 2006, 41, 645-650.
34. Darwish, I.; Liles, W.C. Emerging therapeutic strategies to prevent infection-related microvascular endothelial activation and dysfunction. Virulence 2013, 4, 572-582.
35. Sankar, V.; Webster, N.R. Clinical application of sepsis biomarkers. J. Anesth. 2013, 27, 269-283.
36. Banerjee, S.; Jia, Y.; Siburt, C.J.; Abraham, B.; Wood, F.; Bonaventura, C.; Henkens, R.; Crumbliss, A.L.; Alayash, A.I. Haptoglobin alters oxygenation and oxidation of hemoglobin and decreases propagation of peroxide-induced oxidative reactions. Free Radic. Biol. Med. 2013, 53, 1317-1326.
37. Buehler, P.W.; Abraham, B.; Vallelian, F.; Linnemayr, C.; Pereira, C.P.; Cipollo, J.F.; Jia, Y.; Mikolajczyk, M.; Boretti, F.S.; Schoedon, G.; et al. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood 2009, 113, 2578-2586.